Proapoptotic Effects of Caspase-1/Interleukin-Converting Enzyme Dominate in Myocardial Ischemia

Caspase-1/interleukin-converting enzyme (ICE) is a cysteine protease traditionally considered to have importance as an inflammatory mediator, but not as an apoptotic effector. Because of the dual functions of this caspase, the pathophysiological impact of its reported upregulation in hypertrophy and heart failure is not known. Here, the consequences of increased myocardial expression of procaspase-1 were examined on the normal and ischemically injured heart. In unstressed mouse hearts with a 30-fold increase in procaspase-1 content, unprocessed procaspase-1 was well tolerated, without detectable pathology. Cardiomyocyte processing and activation of caspase-1 and caspase-3 occurred after administration of endotoxin or with transient myocardial ischemia. In post-ischemic hearts, procaspase-1 overexpression was associated with strikingly increased cardiac myocyte apoptosis in the peri- and noninfarct regions and with 50% larger myocardial infarctions. Tissue culture studies revealed that procaspase-1 processing/activation is stimulated by hypoxia, and that caspase-1 acts in synergy with hypoxia to stimulate caspase-3 mediated apoptosis without activating upstream caspases. These data demonstrate that the proapoptotic effects of caspase-1 can significantly impact the myocardial response to ischemia and suggest that conditions in which procaspase-1 in the heart is increased may predispose to apoptotic myocardial injury under conditions of physiological stress.

[1]  S. Goldstein,et al.  Chronic therapy with metoprolol attenuates cardiomyocyte apoptosis in dogs with heart failure. , 2000, Journal of the American College of Cardiology.

[2]  R. Virmani,et al.  Apoptosis in myocytes in end-stage heart failure. , 1996, The New England journal of medicine.

[3]  L. Kirshenbaum,et al.  Caspase activation and mitochondrial cytochrome C release during hypoxia-mediated apoptosis of adult ventricular myocytes. , 2000, Journal of molecular and cellular cardiology.

[4]  Patrick R. Griffin,et al.  Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis , 1995, Nature.

[5]  G M Cohen,et al.  Caspases: the executioners of apoptosis. , 1997, The Biochemical journal.

[6]  J. Martini,et al.  Ischemic preconditioning attenuates ischemia/reperfusion-induced activation of caspases and subsequent cleavage of poly(ADP-ribose) polymerase in rat hearts in vivo. , 1999, Cardiovascular research.

[7]  G. Brown,et al.  Release of mitochondrial cytochrome c and activation of cytosolic caspases induced by myocardial ischaemia. , 2001, Biochimica et biophysica acta.

[8]  M. Paskind,et al.  Mice deficient in IL-1 beta-converting enzyme are defective in production of mature IL-1 beta and resistant to endotoxic shock. , 1995, Cell.

[9]  R. McIntyre,et al.  Neutralization of IL-18 attenuates lipopolysaccharide-induced myocardial dysfunction. , 2002, American journal of physiology. Heart and circulatory physiology.

[10]  J. Mountz,et al.  The Prodomain of Caspase-1 Enhances Fas-mediated Apoptosis through Facilitation of Caspase-8 Activation* , 2000, The Journal of Biological Chemistry.

[11]  G. Dorn,et al.  Ischemic Protection and Myofibrillar Cardiomyopathy: Dose-Dependent Effects of In Vivo &dgr;PKC Inhibition , 2002, Circulation research.

[12]  Simon C Watkins,et al.  Overexpression of tumor necrosis factor- alpha activates both anti- and pro-apoptotic pathways in the myocardium. , 2001, Journal of molecular and cellular cardiology.

[13]  M. Su,et al.  Altered cytokine export and apoptosis in mice deficient in interleukin-1 beta converting enzyme. , 1995, Science.

[14]  G. Dorn,et al.  Opposing cardioprotective actions and parallel hypertrophic effects of delta PKC and epsilon PKC. , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[15]  Yigong Shi,et al.  Mechanisms of caspase activation and inhibition during apoptosis. , 2002, Molecular cell.

[16]  J. Ross,et al.  Loss of a gp130 Cardiac Muscle Cell Survival Pathway Is a Critical Event in the Onset of Heart Failure during Biomechanical Stress , 1999, Cell.

[17]  M. Lenardo,et al.  Roles of caspases in apoptosis, development, and cytokine maturation revealed by homozygous gene deficiencies. , 2000, Journal of cell science.

[18]  M. Todaro,et al.  Heart-targeted overexpression of caspase3 in mice increases infarct size and depresses cardiac function , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[19]  F. Marumo,et al.  Hypoxia induces apoptosis with enhanced expression of Fas antigen messenger RNA in cultured neonatal rat cardiomyocytes. , 1994, Circulation research.

[20]  Wan-Wan Lin,et al.  Attenuation of increased myocardial ischaemia‐reperfusion injury conferred by hypercholesterolaemia through pharmacological inhibition of the caspase‐1 cascade , 2003, British journal of pharmacology.

[21]  S. Nagata,et al.  Sequential activation of ICE-like and CPP32-like proteases during Fas-mediated apoptosis , 1996, Nature.

[22]  J. Gruen,et al.  Peaks of linkage are localized by a BAC/PAC contig of the 6p reading disability locus. , 2001, Genomics.

[23]  R. Kitsis,et al.  A mechanistic role for cardiac myocyte apoptosis in heart failure. , 2003, The Journal of clinical investigation.

[24]  I. Bathurst,et al.  Prevention of rat neonatal cardiomyocyte apoptosis induced by simulated in vitro ischemia and reperfusion , 1997, Cell Death and Differentiation.

[25]  P. Anversa,et al.  Acute myocardial infarction in humans is associated with activation of programmed myocyte cell death in the surviving portion of the heart. , 1996, Journal of molecular and cellular cardiology.

[26]  G. Dorn,et al.  Mitochondrial death protein Nix is induced in cardiac hypertrophy and triggers apoptotic cardiomyopathy , 2002, Nature Medicine.

[27]  G. Dorn,et al.  Inhibition of Cardiac Myocyte Apoptosis Improves Cardiac Function and Abolishes Mortality in the Peripartum Cardiomyopathy of G&agr;q Transgenic Mice , 2003, Circulation.

[28]  Junying Yuan,et al.  Induction of apoptosis in fibroblasts by IL-1β-converting enzyme, a mammalian homolog of the C. elegans cell death gene ced-3 , 1993, Cell.

[29]  G. Dorn,et al.  Transgenic Gαq overexpression induces cardiac contractile failure in mice , 1997 .

[30]  R. Neviere,et al.  Caspase inhibition prevents cardiac dysfunction and heart apoptosis in a rat model of sepsis. , 2001, American journal of respiratory and critical care medicine.

[31]  W. MacLellan,et al.  Death by design. Programmed cell death in cardiovascular biology and disease. , 1997, Circulation research.

[32]  G. Dorn,et al.  Phenotyping hypertrophy: eschew obfuscation. , 2003, Circulation research.

[33]  C A Beltrami,et al.  Apoptosis in the failing human heart. , 1997, The New England journal of medicine.

[34]  Simon C Watkins,et al.  Overexpression of tumor necrosis factor-α activates both anti- and pro-apoptotic pathways in the myocardium , 1999 .

[35]  K. O. Elliston,et al.  A novel heterodimeric cysteine protease is required for interleukin-1βprocessing in monocytes , 1992, Nature.

[36]  R. Knight,et al.  Ischemia-induced STAT-1 Expression and Activation Play a Critical Role in Cardiomyocyte Apoptosis* , 2000, The Journal of Biological Chemistry.

[37]  R. Neviere,et al.  Differential effects of caspase inhibitors on endotoxin-induced myocardial dysfunction and heart apoptosis. , 2001, American journal of physiology. Heart and circulatory physiology.

[38]  A. Harken,et al.  Inhibition of caspase 1 reduces human myocardial ischemic dysfunction via inhibition of IL-18 and IL-1β , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[39]  A. Saraste,et al.  Apoptosis in human acute myocardial infarction. , 1997, Circulation.

[40]  G. Christensen,et al.  Increased cardiac IL-18 mRNA, pro-IL-18 and plasma IL-18 after myocardial infarction in the mouse; a potential role in cardiac dysfunction. , 2003, Cardiovascular research.

[41]  R. Kamen,et al.  Mice deficient in IL-1β-converting enzyme are defective in production of mature IL-1β and resistant to endotoxic shock , 1995, Cell.

[42]  D. Mann,et al.  In vivo expression of proinflammatory mediators in the adult heart after endotoxin administration: the role of toll-like receptor-4. , 2001, The Journal of infectious diseases.

[43]  G. Dorn,et al.  Genetic Causes of Cardiac Hypertrophy Divergent Transcriptional Responses to Independent , 2022 .

[44]  K. Maehara,et al.  Attenuation of ischemia/reperfusion injury in rats by a caspase inhibitor. , 1998, Circulation.

[45]  B. Aronow,et al.  Absence of Poly(ADP-ribose) Polymerase-1 Alters Nuclear Factor-κB Activation and Gene Expression of Apoptosis Regulators after Reperfusion Injury , 2003, Molecular medicine.

[46]  G. Dorn,et al.  Opposing cardioprotective actions and parallel hypertrophic effects of δPKC and ɛPKC , 2001, Proceedings of the National Academy of Sciences of the United States of America.